No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Leerink Partners Maintains Zura Bio(ZURA.US) With Buy Rating, Maintains Target Price $12
Zura Bio (ZURA) Receives a Buy From Piper Sandler
Leerink Partners Maintains Zura Bio(ZURA.US) With Buy Rating, Cuts Target Price to $12
Optimistic Outlook on Zura Bio: Tibulizumab's Potential and Market Opportunity
Cantor Fitzgerald Reiterates Overweight on Zura Bioto Overweight
Express News | Zura Bio Ltd : Leerink Partners Cuts Target Price to $12 From $15